Spyre Therapeutics (SYRE) Receivables - Other (2021 - 2023)
Spyre Therapeutics' (SYRE) quarterly Receivables - Other came in at $163000.0 in Q3 2023, down 75.64% YoY from $669000.0 in Q3 2022, and down 90.1% on a QoQ basis from $1.6 million in Q2 2023.
Spyre Therapeutics (SYRE) Receivables - Other (2021 - 2023) Analysis & Trends
Spyre Therapeutics (SYRE) has 3 years of Receivables - Other data on file, last reported at $163000.0 in Q3 2023.
- Quarterly Receivables - Other fell 75.64% year-over-year to $163000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $163000.0 (down 75.64% YoY) and the FY2022 annual result came in at $375000.0, down 53.99% from the prior year.
- Receivables - Other eased to $163000.0 in Q3 2023, from $1.6 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.6 million in Q2 2023 to a low of $163000.0 in Q3 2023.
- A 3-year average of $686125.0 and a median of $574000.0 in 2022 frame the typical range for Receivables - Other.
- The widest YoY moves for Receivables - Other: up 243.63% in 2023, down 75.64% in 2023.
- Tracing SYRE's Receivables - Other over 3 years: stood at $815000.0 in 2021, then tumbled by 53.99% to $375000.0 in 2022, then tumbled by 56.53% to $163000.0 in 2023.
- The last three Receivables - Other figures came in at $163000.0 (Q3 2023), $1.6 million (Q2 2023), and $330000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Spyre Therapeutics | 9.13 Bn | 9.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 163,000.00 |
| Sep 30, 2023 | 163,000.00 |
| Jun 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 330,000.00 |
| Mar 31, 2023 | 330,000.00 |
| Dec 31, 2022 | 375,000.00 |
| Dec 31, 2022 | 375,000.00 |
| Sep 30, 2022 | 669,000.00 |
| Sep 30, 2022 | 669,000.00 |
| Jun 30, 2022 | 479,000.00 |
| Jun 30, 2022 | 479,000.00 |
| Mar 31, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 815,000.00 |
| Dec 31, 2021 | 815,000.00 |